Increasing Prevalence Of Autoimmune Diseases Driving Market Growth Through Targeted Treatment Innovations Is Supporting Development Across The Leukapheresis Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Increase In Market Value Is Predicted For The Leukapheresis Market During The 2026–2030 Period?

The leukapheresis market size has experienced robust expansion in recent years. Its value is projected to rise from $72.02 billion in 2025 to $77.7 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.9%. The market’s historical growth can be attributed to several factors including an increase in hematologic disorders, the expansion of cancer research programs, the growing utilization of apheresis in blood centers, advancements in centrifugation technologies, and a rise in clinical research funding.

The leukapheresis market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach a value of $104.27 billion, demonstrating a compound annual growth rate (CAGR) of 7.6%.

Several factors are expected to drive this growth during the forecast period. These include the expansion of CAR-T and other cell-based therapies, increasing financial commitments to immunology research, a growing need for personalized medicine solutions, the broadening scope of biopharmaceutical manufacturing, and continuous technological improvements in automated apheresis systems.

Key trends identified for the forecast period involve the increasing application of leukapheresis within cell and gene therapies, a heightened requirement for immune cell collection in cancer treatment, the wider implementation of automated apheresis systems, the extended use of leukapheresis in clinical studies, and an amplified emphasis on disposable, patient-safe apheresis kits.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24277&type=smp

What Market Drivers Are Helping Shape The Leukapheresis Market Expansion?

The increasing prevalence of autoimmune conditions is anticipated to drive the expansion of the leukapheresis market in the future. These diseases are characterized by the immune system erroneously attacking the body’s healthy cells and tissues. Disruptions to immune equilibrium, stemming from diminished early-life microbial exposure and contemporary environmental elements, are contributing to an escalation in autoimmune disorders. Leukapheresis offers a therapeutic approach for autoimmune diseases by selectively eliminating the detrimental white blood cells involved in the immune system’s assault on the body’s tissues. For example, data from September 2025, provided by GetValue.co, a US-based online digital platform, indicates that autoimmune diseases impact an estimated 3–10% of the worldwide population, which translates to approximately 600–800 million individuals globally. Consequently, the growing incidence of autoimmune diseases is a significant factor propelling the expansion of the leukapheresis market.

Which Segment Divisions Form The Structure Of The Leukapheresis Market?

The leukapheresis market covered in this report is segmented –

1) By Apheresis Type: Granulocyte Apheresis, Lymphocyte Apheresis, Monocyte Apheresis

2) By Product: Leukapheresis Devices, Centrifugal Devices, Membrane Separators, Leukapheresis Disposables

3) By Application: Research Application, Cancer Research, Immunology Research, Therapeutics Application, Hematologic Disorders, Autoimmune Diseases, Other Applications

4) By End User: Blood Component Providers And Blood Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Transfusion Centers

Subsegments:

1) By Granulocyte Apheresis: Neutrophil Apheresis, Eosinophil Apheresis, Basophil Apheresis

2) By Lymphocyte Apheresis: T-Cell Apheresis, B-Cell Apheresis, Natural Killer (NK) Cell Apheresis

3) By Monocyte Apheresis: Classical Monocytes, Non-Classical Monocytes, Intermediate Monocytes

What Trends Are Influencing The Leukapheresis Market?

Major companies in the leukapheresis market are concentrating on advancements like creating GMP-grade leukopaks to enhance the quality and efficiency of cell therapy manufacturing. GMP-grade leukopaks are leukapheresis-derived products processed under stringent good manufacturing practice (GMP) standards, ensuring high viability and functionality of collected cells for therapeutic applications. For instance, in November 2024, Sanguine Biosciences, a US-based biotechnology company, launched LeukoCer, a GMP-grade leukopak designed to streamline workflows and accelerate cell therapy development. LeukoCert offers high-quality starting materials available in fresh whole or half packs, produced according to strict GMP standards, thereby empowering researchers to advance their research and bring new cell therapies to market faster.

Which Companies Form The Competitive Landscape Of The Leukapheresis Market?

Major companies operating in the leukapheresis market are Fresenius Kabi, Grifols S.A., Terumo BCT Inc., Nikkiso Co., Haemonetics Corporation, Macopharma, MEDICA S.p.A, Caltag Medsystems Ltd., Miltenyi Biotec, Puriblood Medical, Cytopheron Technologies, STEMCELL Technologies Inc., Discovery Life Sciences, BioIVT LLC, StemExpress LLC, AllCells LLC, HemaCare Corporation, Key Biologics LLC, Immune Therapy Holdings AB, Cellsep Laboratories

Access The Complete Leukapheresis Market Report:

https://www.thebusinessresearchcompany.com/report/leukapheresis-global-market-report

Which Region Holds The Largest Share In The Leukapheresis Market?

North America was the largest region in the leukapheresis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leukapheresis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Leukapheresis Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24277&type=smp

Browse Through More Reports Similar to the Global Leukapheresis Market 2026, By The Business Research Company

Leqembi Market Report 2026

https://www.thebusinessresearchcompany.com/report/leqembi-global-market-report

Leukemia Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/leukemia-therapeutics-global-market-report

Chronic Myeloid Leukemia Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-myeloid-leukemia-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795